Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
299 participants
OBSERVATIONAL
2015-03-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
FIRM (Focal Impulse and Rotor Modulation) guided ablation is defined as ablating rotors identified by the FIRMap® basket catheter for visualising of rotors with the RhythmView® mapping system. In addition to the FIRM guided ablation any other ablation method could be applied.The acute success of FIRM ablations is defined as elimination of rotors defined by absence of rotors.
Data items will be collected, if available, consistent and applicable with routine and standard clinical care at each participating site.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topera C-FIRM Registry
NCT02407249
Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures
NCT02274857
MIFI Flutter Registry - Ablation of Atrial Flutter With IntellaTip Sensor Technology
NCT02810938
Affera Global Registry
NCT06026345
AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation
NCT05481359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
As this is a registry only data of patients will be included who have been treated according to the current AF guidelines.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I-Med-Pro GmbH
OTHER
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerhard Hindricks, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Herzzentrum Leipzig - Universitätsklinik
Kristin Ruffner, PhD
Role: STUDY_DIRECTOR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Städtisches Klinikum Karlsruhe GmbH
Karlsruhe, Baden-Würtemberg, Germany
Herz- und Gefäßklinik
Bad Neustadt an der Saale, Bavaria, Germany
Klinikum Coburg GmbH
Coburg, Bavaria, Germany
Kardiologische Gemeinschaftspraxis am Park Sanssouci
Potsdam, Brandenburg, Germany
Herz- und Diabeteszentrum NRW
Bad Oeynhausen, North Rhine-Westphalia, Germany
Zentrum für klinische Prüfungen in der Facharztzentrum Dresden-Neustadt GbR
Dresden, Saxony, Germany
Herzzentrum Leipzig
Leipzig, Saxony, Germany
Unfallkrankenhaus Berlin
Berlin, , Germany
Erasmus Medical Center
Rotterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-FIRM 02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.